Clinical evaluation indices for hemodialysis/hemodiafiltration in Japan

Area of Science:

• Nephrology
• Internal Medicine
• Public Health

Background:

• Japanese hemodialysis patients exhibit longer chronic hemodialysis (HD) periods and superior clinical outcomes compared to American and European patients.
• This disparity may stem from the significantly lower prevalence of renal transplantation in Japan.
• Consequently, younger, healthier patients suitable for transplantation are often maintained on long-term HD therapy.

Purpose of the Study:

• To investigate the factors contributing to the unique characteristics of Japanese hemodialysis patients.
• To compare clinical outcomes and treatment modalities between Japanese and Western hemodialysis populations.

Main Methods:

• Comparative analysis of clinical outcomes and treatment practices in Japanese hemodialysis patients versus those in Western countries.
• Examination of the prevalence of renal transplantation, dialysis membrane types, and vascular access modalities.

Main Results:

• Japanese patients demonstrate longer durations of chronic HD and better clinical outcomes.
• Lower renal transplantation rates in Japan contribute to prolonged HD therapy for suitable candidates.
• Higher utilization of biocompatible high-flux dialyzers and lower use of arteriovenous grafts are noted in Japan.
• The impact of online hemodiafiltration, despite its potential benefits, remains limited due to low prevalence in Japan.

Conclusions:

• The extended duration and improved outcomes in Japanese hemodialysis patients are associated with specific treatment strategies and lower transplantation rates.
• Biocompatible membranes and reduced reliance on arteriovenous grafts may play a role in these favorable results.
• Further research is needed to assess the broader impact of advanced therapies like online hemodiafiltration in Japan.